Nobuyuki Koyama - Concepedia

Author

Nobuyuki Koyama

Saitama Medical University ORCID

Also Known As

Koyama Nobuyuki, Koyama, N., Koyama, Nobuyuki, N Koyama, N. Koyama, NOBUYUKI KOYAMA, Nobuyuki KOYAMA, Nobuyuki Koyama

Publications

Citations

H-Index

Concepts

All Affiliations

Saitama Medical University Tokyo Medical University Hachioji Medical Center Jichi Medical University Tokyo Medical University Jichi Medical University Saitama Medical Center

About

Nobuyuki Koyama is an author at Saitama Medical University specializing in medicine, lung cancer, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	193
2	Cell Biology	2	2	64
3	Pathology	1	1	41
4	Surgical Oncology	1	1	28
5	Autoimmune Disease	1	1	41

Nobuyuki Koyama

Publications

866

Citations

H-Index

Page 1

	Year	Citations
Gefitinib for non-small-cell lung cancer patients with epidermal growth factor receptor gene mutations screened by peptide nucleic acid-locked nucleic acid PCR clamp Akihisa Sutani, Yuji Nagai, Kiyoshi Udagawa, British Journal of Cancer	2006	167
Reliability of the peptide nucleic acid‐locked nucleic acid polymerase chain reaction clamp‐based test for epidermal growth factor receptor mutations integrated into the clinical practice for non‐small cell lung cancers Tomoaki Tanaka, Yoshiaki Nagai, Hitoshi Miyazawa, Cancer Science	2006	102
Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer Huqun, R. Ishikawa, Jialing Zhang, Cancer	2011	95
Peptide nucleic acid–locked nucleic acid polymerase chain reaction clamp‐based detection test for gefitinib‐refractory T790M epidermal growth factor receptor mutation Hitoshi Miyazawa, Tomoaki Tanaka, Yoshiaki Nagai, Cancer Science	2008	79
Homozygosity Haplotype Allows a Genomewide Search for the Autosomal Segments Shared among Patients Hitoshi Miyazawa, Masaaki Kato, Takuya Awata, The American Journal of Human Genetics Homozygosity HaplotypeHaplotype DeterminationSystems BiologyMendelian DisorderGenetic Disorder	2007	60
Efficacy and safety of nivolumab in 100 patients with recurrent or metastatic head and neck cancer – a retrospective multicentre study Isaku Okamoto, Hiroki Sato, Takahito Kondo, Acta Oto-Laryngologica	2019	50
Advanced Lung Adenocarcinoma with Nivolumab-associated Dermatomyositis Fumiaki Kudo, Yasutaka Watanabe, Yuki Iwai, Internal Medicine Translational MedicineMuscle WeaknessAutoimmune DiseaseMedicineImmunodeficiencies	2018	41
Hypercapnic tumor microenvironment confers chemoresistance to lung cancer cells by reprogramming mitochondrial metabolism in vitro Ryota Kikuchi, Yuki Iwai, Takao Tsuji, Free Radical Biology and Medicine OncologyMitochondrial FunctionMetabolic ReprogrammingMedicineBiological Microenvironments	2019	40
Prognostic Factors and Efficacy of First-Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study Ryo Ko, Takehito Shukuya, Yusuke Okuma, The Oncologist	2018	29
A clinicopathological study of surgically resected lung cancer in patients with usual interstitial pneumonia Yasutaka Watanabe, Yoshinori Kawabata, Nobuyuki Koyama, Respiratory Medicine Surgical OncologyInterventional PulmonologyAdvanced Lung DiseaseSurgical PathologyBronchial Neoplasm	2017	28

Page 1